SP Technical Research Institute of Sweden is a leading international research institute. Regenics AS have a research collaborative agreement with SP Technical Research Institute under the Eurostars EU research program (see News). SP Technical Research Institute performs device development, stability and shelf life testing of Vernex™ as well as further experimental development of the wound healing device Vernex™. 

SP Technical Research Institute work closely with our customers to create value, delivering high-quality input in all parts of the innovation chain, and thus playing an important part in assisting the competitiveness of industry and its evolution towards sustainable development.

 

Contact information:

Address:
Chemistry, Materials and Surfaces
Box 5607, SE-114 86 Stockholm
Sweden

Website: www.sp.se

Regenics' contact person:
Helena Bysell, PhD
Project Manager 
e-mail: helena.bysell@sp.se

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.